| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Cepeprubart | SelK-2 | Phase 2 Clinical | Selexys | Venous Thromboembolism; Asthma; Pulmonary Disease, Chronic Obstructive | Details |
| Leiolizumab | ALTB-268; AbGn-168H2; AbGn 168H2; AbGn-268 | Phase 2 Clinical | Colitis, Ulcerative | Details | |
| Neihulizumab | AbGn-168; AbGn-168H | Phase 1 Clinical | Abgenomics | Graft vs Host Disease; Psoriasis; Colitis, Ulcerative; Arthritis, Psoriatic | Details |
| SSGJ-617 | SSGJ-617; SSGJ617; 61X; VTX-0811; 617 | Phase 1 Clinical | Verseau Therapeutics Inc | Solid tumours | Details |




